Inflammatory Arthritis Stable after Switch to Biosimilar Infliximab (CME/CE)

(MedPage Today) -- Disease activity similar 1 year after non-medical switching in Denmark
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news